VEGFA and vitreous hemorrhage: Six weeks after IVT injection of AAV-VEGF (low dose), erythrocytes were present in the vitreous (vitreous hemorrhage; Fig. 3A, black arrow), in accordance with our in vivo imaging data demonstrating increased vascular permeability (see Fig. 2).